Palantir Insider Files Form 144 for $34M Sale on 08/20/2025

Rhea-AI Filing Summary

Palantir Technologies Inc. (PLTR) filing a Form 144 notifies the proposed sale of 225,000 common shares through Morgan Stanley Smith Barney LLC on 08/20/2025 with an aggregate market value of $34,057,395.00. The filing reports the shares were acquired as restricted stock from the issuer on 08/20/2025 and paid for the same day. The filing shows total shares outstanding of 2,371,337,421 and lists multiple recent sales by Shyam Sankar in May and June 2025, including a 375,000-share sale on 06/10/2025 for $49,528,650.00. The notice includes the required certification that the seller is not aware of undisclosed material adverse information.

Positive

• Disclosure provided under Rule 144 gives market transparency about planned insider sales
• Brokered through Morgan Stanley Smith Barney LLC, indicating use of an established execution channel

Negative

• Proposed sale is sizeable—225,000 shares valued at $34,057,395, which adds near-term selling pressure risk
• Multiple recent large sales by the same individual (e.g., 375,000 shares on 06/10/2025 for $49,528,650) suggest sustained insider monetization

Insights

Securities Analyst

TL;DR: Officer insider sales are sizable and disclosed; recent large disposals may affect short-term float and market perception.

The Form 144 documents a proposed sale of 225,000 Palantir shares valued at $34.06 million executed through a major broker on NASDAQ. The seller reports the securities were restricted stock acquired and paid for on the same date of the proposed sale, which could reflect disposition of newly vested awards or planned liquidity. The filing also catalogs substantial prior disposals by the same individual in May and June 2025, including a 375,000-share sale generating $49.5 million, indicating a pattern of recent monetization. For investors, repeated large insider sales are a noteworthy disclosure though Form 144 itself does not prove undisclosed negative information; it primarily signals increased insider supply to the market.

Corporate Governance Expert

TL;DR: The filing meets Rule 144 disclosure requirements but highlights concentrated insider sales activity requiring governance context.

The notice is procedural and includes the statutory attestation regarding material nonpublic information. It shows shares were acquired as restricted stock and are being offered through an established broker, consistent with standard compliance processes. Governance implications hinge on why restricted shares are being sold immediately after acquisition and the cumulative size of recent sales by the same person. Stakeholders should review the insider's trading plan disclosures, vesting schedules, and any company announcements contemporaneous with these sales to assess whether these transactions are routine compensation monetizations or part of broader insider rebalancing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	225000	34057395.00	2371337421	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2025	Restricted Stock	Issuer			225000	08/20/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shyam Sankar 1200 17TH STREET, FLOOR 15 Denver CO 80202	Common	06/10/2025	8230	1070887.60
Shyam Sankar 1200 17TH STREET, FLOOR 15 Denver CO 80202	Common	06/10/2025	84336	11056744.78
Shyam Sankar 1200 17TH STREET, FLOOR 15 Denver CO 80202	Common	06/10/2025	169629	22378153.16
Shyam Sankar 1200 17TH STREET, FLOOR 15 Denver CO 80202	Common	06/10/2025	137886	18327296.94
Shyam Sankar 1200 17TH STREET, FLOOR 15 Denver CO 80202	Common	06/10/2025	4919	657840.50
SHYAM SANKAR 1200 17TH STREET, FLOOR 15 Denver CO 80202	Common	06/10/2025	375000	49528650.00
SHYAM SANKAR 1200 17TH STREET, FLOOR 15 Denver CO 80202	Common	05/21/2025	6047	757450.24
SHYAM SANKAR 1200 17TH STREET, FLOOR 15 Denver CO 80202	Common	05/21/2025	7726	974837.32
SHYAM SANKAR 1200 17TH STREET, FLOOR 15 Denver CO 80202	Common	05/21/2025	2958	375233.24

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Palantir's (PLTR) Form 144 filed here disclose?

The filing discloses a proposed sale of 225,000 common shares on 08/20/2025 via Morgan Stanley Smith Barney LLC with aggregate market value $34,057,395.00.

Who is listed as having sold shares recently in this filing for PLTR?

The filing lists Shyam Sankar with multiple sales in May and June 2025, including a 375,000-share sale on 06/10/2025 for $49,528,650.00.

Were the 225,000 shares being sold acquired recently or long-held?

The filing states the 225,000 shares were acquired as restricted stock from the issuer on 08/20/2025 and paid for on that same date.

Through which exchange and broker will the PLTR shares be sold?

The sale is to occur on NASDAQ through Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York.

Does the Form 144 assert the seller has undisclosed material information?

Yes, the required signature section includes the seller's representation that they do not know any material adverse information about the issuer that has not been publicly disclosed.